From Nikkei Asia · · 40s
Zoetis targets Japan pet meds market
Zoetis plans potential blockbuster pet medicines for Japan as pet lifespans rise.
In brief
Zoetis plans potential blockbuster pet medicines for Japan as pet lifespans rise. Zoetis, a Pfizer offshoot, will launch cancer and chronic illness treatments for pets in Japan as cats and dogs live longer. Originally reported by Nikkei Asia.
Zoetis enters japan pet market
Zoetis, a Pfizer offshoot, plans potential blockbuster pet medicines for Japan as household animals live longer.
Growing pet health spending
The lifespans of cats and dogs are growing longer, leading to increased spending on medicines and treatments.
Market expansion for pets
Companies like U.S.-based Zoetis launch new therapeutics in Japan to address rising demand for cancer and chronic illness treatments.
The one thing
Zoetis, a Pfizer offshoot, will launch cancer and chronic illness treatments for pets in Japan as cats and dogs live longer.
